UBS AM’s Gyre Therapeutics GYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$52K Hold
7,095
– – ﹤0.01% 3405

Other funds holding GYRE

UBS AM's GYRE Position: Q3 2026 in Review

UBS AM reported 7,095 shares of Gyre Therapeutics (GYRE) worth $52K in Q3 2026. The position accounts for ﹤0.01% of the portfolio, ranked #3405.

58 funds tracked by Wall St. Rank hold GYRE as of Q3 2026.

  • UBS AM held 7,095 shares of Gyre Therapeutics worth $52K as of Q3 2026.
  • Gyre Therapeutics made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3405 holding.
  • 58 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.